NEW YORK — Gencove, the leading low-pass genome sequencing platform, announced today a $3 million investment led by Spero Ventures. Alexandria Venture Investments and Burst Capital participated in the round, along with existing investors Third Kind Venture Capital and Version One Ventures. The funding will be used to develop new applications for agricultural markets as well as expand Gencove’s […]

— Six.02 making significant investments to expand Kemp’s service offerings, infrastructure, and technologies to meet high-growth market for premium protein-based bioservices — FREDERICK, Md.— Six.02 Bioservices announced today the acquisition of Kempbio, a leading provider of gene-to-protein bioservices for innovators developing human and veterinary biopharmaceuticals, vaccines, and diagnostics across the life sciences. Terms of the transaction […]

Oxford Nanopore has today made Flongle starter packs available to purchase, after initial testing in an early-access programme.  Flongle introduces a new paradigm of smaller, on-demand DNA or RNA sequencing tests, with the potential to transform a range of applications where rapid insights are required at low cost. Oxford Nanopore’s goal is to enable the analysis […]

ForteBio, the Biologics Business Unit of Molecular Devices, announced today the availability of a new assay kit for high-throughput glycan screening at the BioProcess International (BPI) West 2019 conference. The Sialic Acid (GlyS) kit, which is designed for use on the industry leading Octet® instruments, presents a revolutionary opportunity to screen for optimal sialylation faster, earlier […]

Madison, WI USA. Promega Corporation’s new Water-Glo™ System offers water plant operators a rapid, highly sensitive and flexible measurement tool for monitoring microbial contamination in freshwater, process water, seawater or wastewater samples. The Water-Glo™ System, launched by Promega this week, uses bioluminescent technology to measure adenosine triphosphate or ATP, the “energy currency” of all living cells that […]

IDBS, a leader in enterprise scientific informatics platforms, is pleased to announce a new SaaS contract with Genevant Sciences Corporation, a leading biopharmaceutical company focused on the discovery and development of a broad range of RNA-based therapeutics across multiple modalities. The arrangement will combine Genevant’s RNA therapeutic expertise with the R&D and discovery data management expertise of IDBS. […]

Othram wins a research grant from Illumina Accelerator and presents at SXSW on breakthrough sequencing and informatics techniques for reconstructing genomes from challenging DNA samples.  THE WOODLANDS, TEXAS Othram, Inc. was awarded a research sequencing grant from Illumina Accelerator after presenting at SXSW for the “Digitizing Biology Through Genomics” session as part of the Energizing […]

Summa Equity acquires Olink Proteomics, a Swedish life science company that has developed a unique technology for human biomarker discovery, targeting the global biopharma and academic research and discovery markets. Olink’s purpose is to enable precision medicine through proteomics, thereby contributing to advancing healthcare worldwide. Summa Equity is excited to support this development, and to […]

Product is the result of a partnership with Integrated DNA Technologies, and provides clinical-stage clients with a critical raw material FARGO, ND: Aldevron, a leading contract development and manufacturing organization serving the biotech industry, announces the release of GMP SpyFi Cas9 Nuclease for clinical and commercial applications. SpyFi Cas9 Nuclease, the trade name for Aldevron’s research grade and GMP […]

BOSTON, MA — NanoView Biosciences, Inc., today announced that it has established a new administrative and demonstration facility near Birmingham, UK. The new office will allow NanoView’s sales, support, and applications team to work more closely with customers in the UK and Europe. NanoView recently launched its first product, ExoView™, to enable accurate identification and […]